Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models

Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions

(2010) M. Golder et al.   BLOOD

Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B

(2010) J. Rayes et al.   BLOOD

The genetic basis of von Willebrand disease

(2010) Anne C. Goodeve   BLOOD REVIEWS

Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza

(2010) A. GÉZSI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factor

(2009) K. VARADI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

(2008) S. L. Haberichter et al.   BLOOD

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

(2008) G. Castaman et al.   BLOOD

Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa

(2008) I. Marx et al.   BLOOD

The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation

(2008) F. Banno et al.   BLOOD

Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease

(2008) M. BOWMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Guidelines and the use of inferior vena cava filters: a review of an institutional experience

(2008) P. SINGH et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS